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A fluorinated bihydrazide conjugate for
activatable sensing and imaging of
hypochlorous acid by 19F NMR/MRI†
Ao Li, ‡ Xiaoxue Tang,‡ Xuanqing Gong, Hongming Chen, Hongyu Lin* and
Jinhao Gao *
Hypochlorous acid (HClO) is one of the most important reactive
oxygen species (ROS) and plays a vital role in many physiological
and pathological processes. The comprehensive exploration of
mechanistic details and the potential clinical translation necessitate
the development of reliable probes for prompt and accurate detection
of HClO in complex biological environments. Herein we report a
fluorinated bihydrazide conjugate as a 19F NMR/MRI probe with a
‘‘turn-on’’ character for the detection of HClO. This probe could
selectively respond to HClO, leading to a significant recovery of
19F signals for 19F NMR/MRI. Activatable sensing and imaging of HClO
were achieved with SMMC-7721 cells and nude mice, which demon-
strates that this small molecular conjugate could serve as a selective
probe for real-time sensing and imaging of HClO in biological systems.
Reactive oxygen species (ROS) are one of the most important
chemical species in biological systems, and include oxygen radicals
such as superoxide (O2
), hydroxyl radicals (HO), peroxyl radicals
(ROO), and non-radical derivatives of oxygen (O2) like singlet
oxygen (1O2), ozone (O3), hydrogen peroxide (H2O2), and hypo-
chlorous acid (HClO).1 They are generated either exogenously or
endogenously (inflammation, metabolism, etc.) and deeply
involved in many physiological and pathological processes.1–5
Among them, hypochlorous acid (HClO) is mostly produced by
the reaction between hydrogen peroxide (H2O2) and chloride
(Cl) catalyzed by myeloperoxidase (MPO).6 In living bodies, the
HClO produced by activated neutrophils through the MPO/H2O2/
Cl system is within 20–400 mM.7 Recent research has established
the close association between uncontrolled upregulation of HClO
and various diseases, such as cardiovascular diseases,8 cancer,9
neuron degeneration,10 and atherosclerosis.11 The elaboration
of mechanistic details and further applications for diagnosis
and therapy rely on real-time and accurate detection of HClO in
complex physiological environments, which underscores the
great demand for HClO sensing and imaging probes. Many
efforts have been dedicated to this field and a variety of probes
have been developed for the detection of HClO in cells and
animal models.12–18 However, most of the probes are based on
fluorescent organic dyes that are susceptible to photobleaching or
oxidation. Furthermore, fluorogenic methods are often restricted
by shallow tissue penetration or autofluorescence interference.
Several approaches trying to overcome these obstacles have been
reported, in spite of their own limitations.19–21
Magnetic resonance imaging (MRI) is a non-invasive imaging
technique with high spatial resolution and deep tissue penetra-
tion which is widely used in clinics and research.22–27 Over the
years, protons (1H) are the only class of nuclei used for MRI
because of their abundance and high sensitivity. As an emerging
complement to conventional 1H MRI, 19F MRI has several
advantages including a comparable sensitivity (83% of 1H), a
broad chemical shift (4350 ppm), and a negligible background
(o106 M in the human body).28,29 As a result, 19F MRI is
considered to be a promising method for imaging bioactive
chemical species. Recently, Kikuchi and co-workers have developed
a few activatable 19F MRI probes for assessing enzymatic
activity.30–32 Several 19F MRI probes aimed at the detection of
ROS, biothiols and cell hypoxia have also been reported.33–37 All
these reports render it appealing to detect and visualize HClO
in organisms with 19F MRI. Unfortunately, to the best of our
knowledge, there has been no study reported on selective
sensing and imaging of HClO with 19F MRI probes.
In this report, we designed a 19F NMR/MRI probe (Gd-DOTA-
BTFPH) small molecular conjugate (Probe 1, as shown in Fig. 1)
for selective detection and imaging of HClO. Probe 1 consists
of a Gd-DOTA complex and a fluorine-containing moiety,
3,5-bis(trifluoromethyl)benzoic acid, which are connected with a
bihydrazide linker. We envisioned that due to the paramagnetic
relaxation enhancement (PRE) effect of Gd-DOTA, the T1 and T2
relaxation times of fluorine atoms in intact Probe 1 should be
significantly reduced, leading to a substantial decrease in the
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intensity of 19F signals.30,38–40 Upon reaction with HClO, which could
selectively oxidize and split the bihydrazide linker,41 the PRE effect
would be markedly undermined, causing the recovery of the T1 and
T2 of the fluorine atoms. As a result, their signal intensity would be
remarkably increased, giving rise to a ‘‘turn-on’’ effect responsive to
HClO. According to the above design, we successfully synthesized
Probe 1 and demonstrated its feasibility and selectivity for the
detection of HClO. Activatable sensing and imaging of HClO were
accomplished with SMMC-7721 cells and nude mice, revealing the
great potential of Probe 1 for real-time detection of HClO in
biological systems.
Construction of Probe 1 was started by preparation of a partially
protected DOTA derivative,42 which was coupled to 3,5-bis(trifluoro-
methyl)benzoic acid via a bihydrazide linker (Scheme S1, ESI†).
Deprotection and chelation with Gd3+ furnished the final product
Probe 1. Detailed synthesis and characterization of 1 and inter-
mediates are included in the ESI.†
To achieve a significant ‘‘turn-on’’ effect, the 19F signal of Probe 1
needs to be sufficiently quenched. We first studied the 19F NMR
signals of DOTA-BTFBH with and without the chelation of Gd3+ ions.
As expected, the 19F NMR spectrum of DOTA-BTFBH itself showed a
single sharp peak at 62.7 ppm, while that of DOTA-BTFBH with
Gd3+ (Probe 1) exhibited a very broad peak that could barely be seen
(Fig. 2a). A further investigation reveals that the fluorine atoms in
Probe 1 have a remarkably shorter transverse relaxation time (T2 =
1.2 ms) than those in DOTA-BTFBH (915 ms) (Table S1, ESI†), which
causes severe line broadening and results in the broad peak in the
19F NMR spectrum.39 These results demonstrate that the presence of
Gd3+ in close proximity could successfully have the PRE effect on
fluorine atoms, significantly shorten their relaxation time, and
considerably abate the 19F signal intensity.30,38–40 Meanwhile, phan-
tom imaging of Probe 1 and Gd-DOTA, a typical clinical MRI contrast
agent, was conducted at 0.5 T (Fig. S1, ESI†). Their longitudinal
relaxivities (r1) were calculated to be 6.15 and 4.78 mM
1 s1,
respectively (Fig. S2, ESI†).
We then investigated the ‘‘turn-on’’ property of Probe 1 in the
presence of HClO. Upon treatment with HClO, the 19F NMR signal of
Probe 1 was considerably recovered (Fig. 2b). The measurement of
relaxation times indicates that after reacting with HClO, which
cleaves the linkage between the Gd3+ complex and the fluorine
atoms, the PRE effect is substantially weakened and the T2 of the
fluorine atoms is recovered (197 ms, Table S1, ESI†). Though the T2
is still shorter than that of the fluorine atoms in DOTA-BTFBH,
which is probably due to the presence of Gd-DOTA resulting from
the cleavage, it is sufficient to lead to a single sharp peak in the
19F NMR spectrum.30 The specificity of Probe 1 was then assessed.
No appreciable recovery of the 19F NMR signal was observed with
a variety of other ROS (H2O2, ROO, HO, O2
) and common
biological molecules/macromolecules (GSH, FBS). Peroxynitrite
(ONOO) did react with Probe 1. However, the recovered 19F NMR
signal was far from comparable to that of HClO treated Probe 1,
which was also supported by quantitative analysis of 19F NMR signals
(Fig. S3, ESI†). This ‘‘turn-on’’ property of Probe 1 was also validated
with preliminary 19F MRI experiments. The 19F MRI ‘‘hot spot’’
signal was remarkably enhanced after treatment with HClO, while in
the presence of both HClO and its scavenger taurine, no detectable
19F MRI signal was observed (Fig. 2c and Fig. S4, ESI†).
To further confirm the cleavage induced by HClO, high perfor-
mance liquid chromatography (HPLC) was used to track this process
(Fig. 2d). After treating Probe 1 with HClO, the original peak for
Probe 1 at 30 min shrank distinctly and an intense peak of 3,5-bis-
trifluoromethyl-benzoic acid appeared at 60 min. In contrast, the
treatment of Probe 1 with both HClO and taurine resulted in the
appearance of a little peak for 3,5-bis-trifluoromethyl-benzoic acid.
Collectively, these results demonstrate that Probe 1 could specifically
respond to HClO without the interference from other ROS, leading to
a significant signal recovery for 19F NMR/MRI due to the cleavage of
the bihydrazide, which could be exploited for the visualization of
HClO in organisms.
The behavior of the 19F MRI signal recovery of Probe 1 in the
presence of HClO was further investigated. The concentration
dependence of the signal recovery was first studied. A series of
solutions containing Probe 1 at different concentrations in the
Fig. 1 Schematic illustration showing the functioning mechanism of the
HClO-activated 19F NMR/MRI probe Gd-DOTA-BTFBH small molecular
conjugate (Probe 1 or 1).
Fig. 2 (a) 19F NMR spectra of DOTA-BTFPH and Probe 1 in PBS buffer (pH 7.4).
(b) 19F NMR spectra of Probe 1 (150 mM) treated with various analytes (0.45 mM)
in PBS buffer for 5 min at 25 1C. CF3COONa (at 75.4 ppm) was used as an
internal reference of chemical shift. (c) 19F ‘‘hot spot’’ MRI phantom images of
PBS, Probe 1 (3 mM), Probe 1 with HClO, and Probe 1 with HClO and taurine
acquired on a 9.4 T MRI scanner. (d) HPLC chromatograms of Probe 1 (1 mM),
Probe 1 incubated with HClO and taurine for 15 min, Probe 1 incubated with
HClO for 15 min, and 3,5-bis-trifluoromethyl-benzoic acid.
Communication ChemComm
Pu
bl
is
he
d 
on
 2
3 
Se
pt
em
be
r 
20
19
. D
ow
nl
oa
de
d 
by
 X
ia
m
en
 U
ni
ve
rs
ity
 o
n 
2/
21
/2
02
0 
7:
14
:2
6 
A
M
. 
View Article Online
This journal is©The Royal Society of Chemistry 2019 Chem. Commun., 2019, 55, 12455--12458 | 12457
presence and absence of HClO were subjected to 19F MRI. The
phantom images show that the intensity of the recovered signal
increased as the concentration of Probe 1 was increased (Fig. 3a).
Quantitative analysis confirms the increasing trend of the signal-to-
noise ratio (SNR) of Probe 1 with the increase of the concentration,
either with or without HClO. Though at high concentrations the
SNRs of Probe 1 with and without HClO were both increased, the
enhancement of the SNR (SNRwith HClO/SNRwithoutHClO) was decreased
(Fig. 3b). The influence of the signal acquiring parameter TE on the
signal recovery was also evaluated. Probe 1 treated with HClO
showed strong signals with TE ranging from 1.3 to 3.9 ms, whereas
Probe 1 alone and Probe 1 treated with HClO and taurine exhibited
weak signals (Fig. 3c). It is noted that the signals of the three
formulations all decreased with the increase of TE. For most
common pulse sequences used for 19F MRI, approximately,
Savg / e
TE
T2 or e
TE
T2
where Savg represents the average signal intensity, T2 is the transverse
relaxation time, and T2* is the time constant for the relaxation
caused by the transverse relaxation and the inhomogeneity of an
external magnetic field.29 In general, T2* o T2. If TE is shorter than
or close to T2 (T2*) of the fluorine atoms, strong or moderate signals
can be observed; on the other hand, if TE is much longer than
T2 (T2*) of the fluorine atoms, the signals become very weak due to
the exponential decay relationship between Savg and TE. Since the
T2 (T2*) of fluorine atoms in Probe 1 alone or Probe 1 treated with
HClO and taurine is very short (T2 = 1.2 ms o TE) due to the PRE
effect, the corresponding 19F MRI signals are weak. In contrast, the
T2 (T2*) of fluorine atoms in Probe 1 treated with HClO is prolonged
because of the cleavage of the bihydrazide and the extinction of the
PRE effect, resulting in T2 (T2*) c TE and strong
19F MRI signals.
The exponential decay relationship between Savg and TE also explains
the abatement of the signal intensities with the extension of TE
(Fig. 3d).
The detection of HClO by 19F NMR at the cellular level was
evaluated with hepatocellular carcinoma SMMC-7721 cells. After
being treated with Probe 1, SMMC-7721 cells were washed with
PBS, and exposed to various stimuli including HClO, excess H2O2,
and HClO + taurine, after which the cells were collected by centri-
fugation and lysed and then subjected to 19F NMR (Fig. 4a). A very
broad peak was observed with the lysate of the cells stimulated with
PBS, suggesting that the concentration of endogenous HClO is too
low to activate Probe 1, which necessitates the introduction of
exogenous HClO. As expected, a strong 19F NMR signal could be
detected with the cells stimulated with HClO (Fig. 4b). In contrast, no
evident change was observed with the lysate of the cells stimulated
with H2O2 up to 15 mM. Addition of taurine successfully prevented
the recovery of the 19F NMR signal, which is consistent with the
aforementioned experiments. A quantitative analysis reveals the
superior relative SNR of the HClO-stimulated group compared to
those of the other groups, indicating the high selectivity of Probe 1
(Fig. 4c). Meanwhile, Probe 1 shows no appreciable cytotoxicity even
at concentrations up to 3 mM (Fig. S5, ESI†). These results reveal the
good cell permeability of Probe 1 and evidence its intracellular
reaction with exogenous HClO, indicating the feasibility and speci-
ficity of Probe 1 for the detection of HClO in cells.
Finally, the capability of Probe 1 for in vivo imaging of HClO was
assessed with nude mice. A nude mouse was subjected to subcuta-
neous injection with Probe 1 into both the left and right flanks
followed by injection of HClO into the right flank. Strong 1H MRI
signals were observed for both the left and right flanks due to the
contrast-enhanced effect of Gd3+ chelate molecules (Gd-DOTA) for
1H MRI. However, a strong 19F MRI signal was only observed for the
right flank, indicating the outstanding specificity of Probe 1 for
imaging of HClO. Quantitative analysis of the merged image reveals
the excellent colocalization of 1H MRI and 19F MRI signals into the
right flank (Fig. 5d). These results demonstrate that Probe 1 is
feasible for in vivo imaging of HClO with 1H MRI providing
anatomical details and 19F MRI offering specific distribution in
deep tissues. Similar to most small molecular probes, challenges
including rapid clearance and limited delivery to targets should be
considered for design in the future to realize the targeted 19F MRI in
living subjects.
Fig. 3 (a) 19F MRI phantom images and (b) the corresponding SNRs of
Probe 1 at different concentrations (with respect to Gd) before and after
being treated with HClO (1 equiv.) for 1 h. (c) 19F MRI phantom images
acquired with different TE values and (d) the corresponding SNRs of Probe 1
(5.5 mM), Probe 1 treated with HClO (1 equiv.), and Probe 1 treated with
HClO (1 equiv.) and taurine (1.2 equiv.).
Fig. 4 (a) Schematic illustration of the protocol for the detection of HClO
with Probe 1 by 19F NMR at the cellular level. (b) 19F NMR spectra of SMMC-
7721 cells incubated with Probe 1 (1.5 mM) for 4 h followed by PBS, H2O2,
HClO (1.5 mM) + taurine (1.8 mM), or HClO (1.5 mM) for 40 min. (c) Relative
SNRs of 19F NMR spectra in (b). The SNR of the PBS-treated sample was
normalized as 1.0. n.s., not significant.
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In summary, we have developed an activatable probe based
on a fluorinated bihydrazide conjugate for sensing and imaging
of hypochlorous acid via 19F NMR/MRI. This small molecular
conjugate could selectively respond to hypochlorous acid, which
cleaves the bihydrazide, leading to the recovery of the 19F signals
that are ‘‘extinguished’’ in the intact probe due to the PRE effect.
The recovered signals could be promptly detected by 19F NMR/
MRI. We believe that this small molecular conjugate holds great
potential as a promising probe for selective detection and real-
time imaging of hypochlorous acid in organisms and would be
inspiring for the design and construction of probes for sensing
and imaging of other chemical species in biological systems.
The authors acknowledge the research support from the
National Natural Science Foundation of China (21771148,
21602186, 21521004, and 81430041), the Natural Science Foun-
dation of Fujian Province of China (2018J01011), and the
Fundamental Research Funds for the Central Universities
(20720170020, 20720170088, and 20720180033).
Conflicts of interest
There are no conflicts of interest.
Notes and references
1 C. C. Winterbourn, Nat. Chem. Biol., 2008, 4, 278–286.
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Fig. 5 (a) 1H and (b) 19F MRI of a nude mouse after subcutaneous injections
of Probe 1 (10 mM, 150 mL) into both the right and left flanks, followed by an
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merged image of (a) and (b). (d) A plot showing the signal intensities of
1H MRI and 19F MRI along the yellow line as indicated in (c), which reveals the
colocalization of 1H MRI and 19F MRI signals in the right flank of the mouse.
Communication ChemComm
Pu
bl
is
he
d 
on
 2
3 
Se
pt
em
be
r 
20
19
. D
ow
nl
oa
de
d 
by
 X
ia
m
en
 U
ni
ve
rs
ity
 o
n 
2/
21
/2
02
0 
7:
14
:2
6 
A
M
. 
View Article Online
